The European-funded GNA NOW Consortium and Nosopharm, a biotechnology company exploring unconventional sources of antibiotics with potential in the fight against antimicrobial resistance, have announced a milestone development following completion and positive results of toxicology studies for a first-in-class antibiotic for the treatment of multidrug-resistant infections. Click to read more.
Dosing has commenced in HMNC Brain Health and Develco Pharma's Phase 2 oral prolonged-release Ketamine (KET01) Study The trial will assess the efficacy, safety, and tolerability of add-on treatment
With over 25 years of experience supporting a large network of UK fume cupboard manufacturers and those working within the laboratory sector, Staffordshire based Axair Fans has extended their large warehouse space to allow them to hold stock and fulfil additional demand for their corrosion resistant polypropylene fans from European manufacturer SEAT Ventilation. Click to read more.
According to A new research at the University of Oxford, a bacterium called Pseudomonas is found which respond to being treated with Colistin, a last resort antibiotic for patients who have developed multi-drug resistant infections.
Organomation’s nitrogen blowdown evaporators are built to stand the test of time due to the use of high quality parts and materials, all sourced within the USA. Click to read more.